KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 63 filers reported holding KINNATE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 193.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,361 | +73.2% | 887,740 | +54.4% | 0.00% | +100.0% |
| Q4 2023 | $1,363 | +92.5% | 574,979 | +13.6% | 0.00% | +100.0% |
| Q3 2023 | $708 | -30.9% | 505,956 | +49.8% | 0.00% | 0.0% |
| Q2 2023 | $1,024 | +48.2% | 337,800 | +205.7% | 0.00% | 0.0% |
| Q1 2023 | $691 | +9.5% | 110,500 | +6.9% | 0.00% | 0.0% |
| Q4 2022 | $631 | -99.9% | 103,400 | +2.9% | 0.00% | -50.0% |
| Q3 2022 | $1,201,000 | -0.4% | 100,500 | +5.1% | 0.00% | +100.0% |
| Q2 2022 | $1,206,000 | +348.3% | 95,600 | +300.0% | 0.00% | – |
| Q1 2022 | $269,000 | -50.0% | 23,900 | +2.3% | 0.00% | -100.0% |
| Q3 2021 | $538,000 | -35.6% | 23,358 | -34.9% | 0.00% | 0.0% |
| Q2 2021 | $836,000 | – | 35,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|